<main class="news-article" lang="en" role="main">
      
<div class="govuk-grid-row">
  <div class="govuk-grid-column-two-thirds">
    

<div class="gem-c-title govuk-!-margin-top-8 govuk-!-margin-bottom-8">
      <span class="govuk-caption-xl gem-c-title__context">
    News story
  </span>


  <h1 class="gem-c-title__text govuk-heading-l">
    World Cancer Day: How new partnerships are helping get breakthrough cancer medicines to patients sooner
  </h1>
</div>
  </div>
  
  <div class="govuk-grid-column-two-thirds">
    
  <p class="gem-c-lead-paragraph">A reflection by Dr June Raine, Chief Executive of the Medicines and Healthcare products Regulatory Agency </p>

  </div>
</div>

<div class="govuk-grid-row">
  <div class="metadata-logo-wrapper">
    <div class="govuk-grid-column-two-thirds metadata-column">
      <div class="gem-c-metadata" data-module="gem-toggle metadata">
  <dl data-module="gem-track-click">
      <dt class="gem-c-metadata__term">From:</dt>
      <dd class="gem-c-metadata__definition">
          <a class="govuk-link" href="/government/organisations/medicines-and-healthcare-products-regulatory-agency">Medicines and Healthcare products Regulatory Agency</a>

      </dd>
      <dt class="gem-c-metadata__term">Published</dt>
      <dd class="gem-c-metadata__definition">10 February 2022</dd>
  </dl>
</div>
    </div>
    <div class="govuk-grid-column-one-third">
    </div>
  </div>
</div>






<div class="govuk-grid-row">
  <div class="govuk-grid-column-two-thirds ">
    <div class="content-bottom-margin">
      <div class="responsive-bottom-margin">
        <figure class="app-c-figure" lang="en">
    <img alt="" class="app-c-figure__image" src="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/image_data/file/142296/s300_Dr-June-Raine-GovUK.jpg">
  <figcaption class="app-c-figure__figcaption">
  </figcaption>
</figure>

        
<div class="gem-c-govspeak govuk-govspeak direction-ltr" data-module="govspeak">
    
          <div class="govspeak">
<p>One in two people will develop cancer in their lifetime. In fact, such is the impact of this devastating disease on the NHS that cancer is named as one of the “great healthcare challenges” outlined by the government’s <a class="govuk-link" href="https://www.gov.uk/government/publications/life-sciences-vision">Life Sciences Vision</a>. So on the 4 February, World Cancer Day 2022, we at the MHRA reflected on what we are doing to confront it.</p>

<p>We are committed to the timely approval of all promising new medicines, not just those relating to cancer. One only needs to look to our authorisation of COVID-19 vaccines and medicines to see this. However, several new partnerships have helped facilitate our authorisations of these cancer treatments more quickly, while maintaining our stringent standards of safety, quality and effectiveness.</p>

<p>In January 2021, we launched a new way of bringing breakthrough medicines to patients more quickly – known as the ‘<a class="govuk-link" href="https://www.gov.uk/guidance/innovative-licensing-and-access-pathway">Innovative Licensing and Access Pathway</a>’. This new pathway is a partnership with other healthcare bodies in England, Scotland and Wales.</p>

<p>We also joined <a class="govuk-link" href="https://www.gov.uk/guidance/guidance-on-project-orbis">Project Orbis</a>, an international coalition of regulators led by the FDA working to provide faster patient access to innovative cancer treatments.</p>

<p>Working with these partnerships, we have recently approved new treatments for lung cancer (Rybrevant, Lumkyras, and Tepmetko) and breast cancer (Trodelvy). We have also extended the use of medicines for lung cancer (Lorviqua and Tagrisso) and oesophageal cancer (Opdivo), so that they can be used to treat more people.</p>

<p>Our new approval pathway builds on our forerunner initiative, the <a class="govuk-link" href="https://www.gov.uk/guidance/apply-for-the-early-access-to-medicines-scheme-eams">Early Access to Medicines Scheme</a> (EAMS) which has so far given hundreds of patients early access to no fewer than 12 cancer treatments. In August 2021, we also asked for public input on the scheme and <a class="govuk-link" href="https://www.gov.uk/government/consultations/early-access-to-medicines-scheme-eams-consultation">the outcome</a> has just been published.</p>

<p>These initiatives are examples of how collaboration, not just with the wider UK healthcare system but with patients and our partner regulators across the world, can help to bring safe, effective and timely treatments to those who need them most.</p>

<h4>This article was originally published in The Express</h4>
</div>

</div>
      </div>

      <div class="dont-print responsive-bottom-margin">
          <div class="gem-c-share-links govuk-!-display-none-print" data-module="gem-track-click">
      <h2 class="gem-c-share-links__title">Share this page</h2>

    <ul class="gem-c-share-links__list">
        <li class="gem-c-share-links__list-item">
          <a class="govuk-link govuk-link--no-underline gem-c-share-links__link " data-track-action="facebook" data-track-category="social media" data-track-options="{&quot;socialAction&quot;:&quot;share&quot;,&quot;socialNetwork&quot;:&quot;facebook&quot;,&quot;socialTarget&quot;:&quot;https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.gov.uk%2Fgovernment%2Fnews%2Fworld-cancer-day-how-new-partnerships-are-helping-get-breakthrough-cancer-medicines-to-patients-sooner&quot;}" href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.gov.uk%2Fgovernment%2Fnews%2Fworld-cancer-day-how-new-partnerships-are-helping-get-breakthrough-cancer-medicines-to-patients-sooner" rel="noopener noreferrer external" target="_blank">
            <span class="gem-c-share-links__link-icon">
                <svg focusable="false" viewBox="0 0 24 24" xmlns="http://www.w3.org/2000/svg">
                  <path d="M24 12.073c0-6.627-5.373-12-12-12s-12 5.373-12 12c0 5.99 4.388 10.954 10.125 11.854v-8.385H7.078v-3.47h3.047V9.43c0-3.007 1.792-4.669 4.533-4.669 1.312 0 2.686.235 2.686.235v2.953H15.83c-1.491 0-1.956.925-1.956 1.874v2.25h3.328l-.532 3.47h-2.796v8.385C19.612 23.027 24 18.062 24 12.073z" fill="currentColor"></path>
                </svg>
            </span>          <span class="govuk-visually-hidden">
              Share on
          </span>
          Facebook
</a>
        </li>
        <li class="gem-c-share-links__list-item">
          <a class="govuk-link govuk-link--no-underline gem-c-share-links__link " data-track-action="twitter" data-track-category="social media" data-track-options="{&quot;socialAction&quot;:&quot;share&quot;,&quot;socialNetwork&quot;:&quot;twitter&quot;,&quot;socialTarget&quot;:&quot;https://twitter.com/share?url=https%3A%2F%2Fwww.gov.uk%2Fgovernment%2Fnews%2Fworld-cancer-day-how-new-partnerships-are-helping-get-breakthrough-cancer-medicines-to-patients-sooner\u0026text=World%20Cancer%20Day%3A%20How%20new%20partnerships%20are%20helping%20get%20breakthrough%20cancer%20medicines%20to%20patients%20sooner&quot;}" href="https://twitter.com/share?url=https%3A%2F%2Fwww.gov.uk%2Fgovernment%2Fnews%2Fworld-cancer-day-how-new-partnerships-are-helping-get-breakthrough-cancer-medicines-to-patients-sooner&amp;text=World%20Cancer%20Day%3A%20How%20new%20partnerships%20are%20helping%20get%20breakthrough%20cancer%20medicines%20to%20patients%20sooner" rel="noopener noreferrer external" target="_blank">
            <span class="gem-c-share-links__link-icon">
                <svg focusable="false" viewBox="0 0 24 24" xmlns="http://www.w3.org/2000/svg">
                  <path d="M23.953 4.57a10 10 0 01-2.825.775 4.958 4.958 0 002.163-2.723c-.951.555-2.005.959-3.127 1.184a4.92 4.92 0 00-8.384 4.482C7.69 8.095 4.067 6.13 1.64 3.162a4.822 4.822 0 00-.666 2.475c0 1.71.87 3.213 2.188 4.096a4.904 4.904 0 01-2.228-.616v.06a4.923 4.923 0 003.946 4.827 4.996 4.996 0 01-2.212.085 4.936 4.936 0 004.604 3.417 9.867 9.867 0 01-6.102 2.105c-.39 0-.779-.023-1.17-.067a13.995 13.995 0 007.557 2.209c9.053 0 13.998-7.496 13.998-13.985 0-.21 0-.42-.015-.63A9.935 9.935 0 0024 4.59z" fill="currentColor"></path>
                </svg>
            </span>          <span class="govuk-visually-hidden">
              Share on
          </span>
          Twitter
</a>
        </li>
    </ul>
</div>
      </div>

      <div class="app-c-published-dates" lang="en">
    Published 10 February 2022
</div>

    </div>
  </div>

  
<div class="govuk-grid-column-one-third">
  


</div>

</div>


  <div class="govuk-grid-row">
    <div class="govuk-grid-column-two-thirds">
        
  <div class="gem-c-contextual-footer">
    
  <div class="gem-c-related-navigation">





      <nav class="gem-c-related-navigation__nav-section" data-module="gem-toggle" role="navigation">

    <h2 class="gem-c-related-navigation__sub-heading gem-c-related-navigation__sub-heading--footer" data-track-count="footerRelatedItemSection">Explore the topic</h2>

  <ul class="gem-c-related-navigation__link-list" data-module="gem-track-click">


        <li class="gem-c-related-navigation__link"><a class="govuk-link govuk-link gem-c-related-navigation__section-link govuk-link gem-c-related-navigation__section-link--footer" data-track-action="1.1 Explore the topic" data-track-category="relatedLinkClicked" data-track-label="/topic/medicines-medical-devices-blood/marketing-authorisations-variations-licensing" data-track-options="{&quot;dimension28&quot;:&quot;1&quot;,&quot;dimension29&quot;:&quot;Marketing authorisations, variations and licensing guidance&quot;}" href="/topic/medicines-medical-devices-blood/marketing-authorisations-variations-licensing">Marketing authorisations, variations and licensing guidance</a></li>

  </ul>
</nav>

  </div>

  </div>


    </div>
  </div>


    </main>